SEPARATION AGREEMENT AND RELEASE OF CLAIMSSeparation Agreement and Release of Claims • July 30th, 2021 • CytoDyn Inc. • Pharmaceutical preparations • Washington
This Separation Agreement and Release of Claims (the “Agreement”) is made and entered into by and between Mahboob U. Rahman, M.D. Ph.D. (“Employee”) and CytoDyn Inc. (“Employer”). It is intended to clearly set forth the terms and conditions of Employee’s separation from employment with Employer, and to facilitate a smooth and amicable transition from employment.
Exclusive Supply and Distribution AgreementExclusive Supply and Distribution Agreement • July 30th, 2021 • CytoDyn Inc. • Pharmaceutical preparations • Delaware
CYTODYN INC. (“CytoDyn”), a corporation incorporated and legally existing under the laws of USA, with its principal office and place of business at 1111 Main Street, Suite 660, Vancouver, Washington 98660, hereby duly represented in accordance with its By-Laws, and
EXCLUSIVE SUPPLY AND DISTRIBUTION AGREEMENTAnd Distribution Agreement • July 30th, 2021 • CytoDyn Inc. • Pharmaceutical preparations
This Exclusive Supply and Distribution Agreement (“Agreement”), made and entered into this 15th day of April, 2021 (“Effective Date”), by and between:
EXCLUSIVE SUPPLY AND DISTRIBUTION AGREEMENTAnd Distribution Agreement • July 30th, 2021 • CytoDyn Inc. • Pharmaceutical preparations • New Jersey
This Exclusive Supply and Distribution Agreement (“Agreement”), made and entered into this 11th day of May, 2021 (“Effective Date”), by and between:
Amendment No.1 to Exclusive Supply and Distribution AgreementCytoDyn Inc. • July 30th, 2021 • Pharmaceutical preparations
This amendment (this “Amendment”), dated as of April 19, 2021, is entered by and between CytoDyn Inc., a Delaware corporation (“CytoDyn”) having a place of business at 1111 Main Street, Vancouver, Washington 98660, and Chiral Pharma Corporation, a Philippines corporation (“CPC”) having a place of business at P. Antonio St., cor F. Legaspi St., Ugong, Pasig, Metro Manila, with respect to the following facts:
